.

Deeper Knowledge, Faster

  • Find suppliers and generic API sources
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

McKinsey
Boehringer Ingelheim
Julphar
US Department of Justice
Argus Health
Citi
Cipla
Mallinckrodt
AstraZeneca
Colorcon

Generated: July 26, 2017

DrugPatentWatch Database Preview

Miconazole nitrate - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for miconazole nitrate and what is the scope of miconazole nitrate patent protection?

Miconazole nitrate
is the generic ingredient in seventeen branded drugs marketed by Actavis Pharma, Medtech Products, Perrigo R And D, G And W Labs, Actavis Mid Atlantic, Perrigo, Teva Pharms, Teva, Insight Pharms, Taro, G And W Labs Inc, Personal Prods, and Mylan Pharms Inc, and is included in thirty NDAs. There are three patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Miconazole nitrate has fourteen patent family members in twelve countries.

There are twenty-eight drug master file entries for miconazole nitrate. Fifty-three suppliers are listed for this compound.

Summary for Generic Name: miconazole nitrate

Tradenames:17
Patents:3
Applicants:13
NDAs:30
Drug Master File Entries: see list28
Suppliers / Packagers: see list53
Bulk Api Vendors: see list66
Clinical Trials: see list129
Patent Applications: see list2,303
Therapeutic Class:Antifungals
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:miconazole nitrate at DailyMed

Pharmacology for Ingredient: miconazole nitrate

Ingredient-typeAzoles
Drug ClassAzole Antifungal
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Medtech Products
MONISTAT 7 COMBINATION PACK
miconazole nitrate
CREAM, SUPPOSITORY;TOPICAL, VAGINAL020288-002Apr 26, 1993OTCYesYes► Subscribe► Subscribe► Subscribe
Perrigo
MICONAZOLE NITRATE
miconazole nitrate
SUPPOSITORY;VAGINAL074395-001Mar 20, 1997OTCNoYes► Subscribe► Subscribe► Subscribe
Actavis Mid Atlantic
M-ZOLE 3 COMBINATION PACK
miconazole nitrate
CREAM, SUPPOSITORY;TOPICAL, VAGINAL074926-001Apr 16, 1999OTCNoNo► Subscribe► Subscribe► Subscribe
G And W Labs Inc
MICONAZOLE NITRATE
miconazole nitrate
CREAM;VAGINAL074366-001Feb 22, 1996OTCNoNo► Subscribe► Subscribe► Subscribe
G And W Labs
MICONAZOLE NITRATE
miconazole nitrate
SUPPOSITORY;VAGINAL074414-001Apr 30, 1997OTCNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: miconazole nitrate

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Insight Pharms
MONISTAT-DERM
miconazole nitrate
CREAM;TOPICAL017494-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Medtech Products
MONISTAT 1 COMBINATION PACK
miconazole nitrate
CREAM, SUPPOSITORY;TOPICAL, VAGINAL021308-001Jun 29, 2001► Subscribe► Subscribe
Insight Pharms
MONISTAT-DERM
miconazole nitrate
LOTION;TOPICAL017739-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Medtech Products
MONISTAT 3
miconazole nitrate
SUPPOSITORY;VAGINAL018888-001Aug 15, 1984► Subscribe► Subscribe
Medtech Products
MONISTAT 3
miconazole nitrate
SUPPOSITORY;VAGINAL018888-001Aug 15, 1984► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: miconazole nitrate

Country Document Number Estimated Expiration
Germany69930725► Subscribe
Japan2002530327► Subscribe
Spain2262353► Subscribe
Argentina021863► Subscribe
China1288379► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Cipla
AstraZeneca
Harvard Business School
UBS
Healthtrust
Boehringer Ingelheim
Citi
Johnson and Johnson
Deloitte
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot